References
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86
- UKPDS Study Group. UK prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995;44:1249-58
- UKPDS Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65
- Tratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12
- American Diabetes Association. Standards of Medical Care in Diabetes—2009: American Diabetes Association. Diabetes Care 2009;32:S13-61
- Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. International Diabetes Federation, 2005. Available at: www.idf.org
- Jellinger PS, Davidson JA, Blonde L, et al. ACE/AACE Diabetes Road Map Task Force. Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force. Endocr Pract 2007;13:260-8
- Radziuk JR. Neutral Protamine Lispro: activity profile of s.c. administration with and without admixture of soluble lispro. Diabetologia 1996;39:A224
- DeFelippis MR, Bakaysa DL, Bell MA, et al. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue. J Pharm Sci 1998;87:170-6
- Roach P, Woodworth JR. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures. Clin Pharmacokinet 2002;41:1043-57
- Schwartz S, Zagar AJ, Althouse SK, et al. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus. Clin Ther 2006;28:1649-57
- Koivisto VA, Tuominen JA, Ebeling P. Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients. Diabetes Care 1999;22:459-62
- Roach P, Strack T, Arora V, et al. Improved glycaemic control with the use of self-prepared mixtures of insulin lispro and insulin lispro protamine suspension in patients with types 1 and 2 diabetes. Int J Clin Pract 2001;55:177-82
- Roach P, Yue L, Arora V. Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group. Diabetes Care 1999;22:1258-61
- Roach P, Trautmann M, Arora V, et al. Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group. Clin Ther 1999;21:523-34
- Herz M, Profozic V, Arora V, et al. Effects of a fixed mixture of 25% insulin lispro and 75% NPL on plasma glucose during and after moderate physical exercise in patients with type 2 diabetes. Curr Med Res Opin 2002;18:188-93
- Malone JK, Beattie SD, Campaigne BN, et al. Therapy after single oral agent failure: adding a second oral agent or an insulin mixture?. Diabetes Res Clin Pract 2003;62:187-95
- Jacober SJ, Scism-Bacon JL, Zagar AJ. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents. Diabetes Obes Metab 2006;8:448-55
- Esposito K, Ciotola M, Maiorino MI, et al. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control. A randomized trial. Ann Intern Med 2008;149:531-9
- Nathan DM, Buse JB, Davidson MB et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2008;31:1-11
- Citro G, Maioli A, Lo Pomo F, et al. Comparison of dietary intake of type I diabetic patients and nutritional recommendations. Minerva Gastroenterol Dietol 1998;44:141-7
- Rivellese AA, Boemi M, Cavalot F, et al.; Mind.it Study Group. Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations?. Eur J Clin Nutr 2008;62:660-4
- Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes – causes, effects and coping strategies. Diabetes Obes Metab 2007;9:799-812
- Malone JK, Bai S, Campaigne BN, et al. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with type 2 diabetes. Diabet Med 2005;22:374-381